| Myxofibrosarcoma studied in …STUDIED_INderived20 of 20show fewer |
|---|
| → studied in | NCT05711615Phase 1 · recruiting Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma · condition mapped CURATED_BROADER · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789172Phase 1 · recruiting A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04332874Phase 2 · recruiting A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420975Phase 1 · active not recruiting Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169344Phase 2 · recruiting Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173972Phase 2 · recruiting Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03425279Phase 1/Phase 2 · completed CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242238Phase 1 · completed Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06370871Phase 3 · withdrawn Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04480502Phase 2 · unknown ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584309Phase 2 · completed Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009201Phase 1 · completed Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601209Phase 1/Phase 2 · terminated Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116800Phase 2 · withdrawn Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906876Phase 2 · withdrawn A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651375Phase 2 · unknown Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01653028Phase 2 · completed Alisertib in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 20 trials mapped (8 active) | — | — | Myxofibrosarcoma | 1 | Observed | clinicaltrials | graph → |